表紙
市場調查報告書
商品編碼
1029948

北美膝關節軟骨修復市場-到 2028 年的行業趨勢和預測

North America Knee Cartilage Repair Market - Industry Trends and Forecast to 2028

出版日期: | 出版商: Data Bridge Market Research Private Limited | 英文 202 Pages | 商品交期: 3-5個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計北美膝關節軟骨修復市場從 2021 年到 2028 年將以 8.0% 的複合年增長率增長。

本報告調查和分析北美膝關節軟骨修復市場、市場監管、價值鏈分析、促進因素、抑制因素、機會、挑戰、COVID-19 影響、治療、手術、設備。我們按地區、應用提供市場信息、最終用戶、分銷渠道、區域市場信息、企業情況、SWOT 分析和企業簡介。

目錄

第 1 章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章膝關節軟骨修復市場監管

  • 美國食品藥品監督管理局
  • 各種產品的臨床批准:
    • 自體□□細胞產品
    • 同種異體細胞產品
    • 注射劑
    • 設備
    • 非臨床數據和測試
  • 臨床試驗、患者群體和臨床終點
    • 患者群體
    • 選擇對照組
    • 臨床終點

第 6 章流行病學

第 7 章行業洞察

第 8 章膝關節軟骨修復的救贖

第 9 章北美軟骨修復市場:價值鏈分析

第 10 章市場概覽

  • 促進因素
    • 老年人口增加
    • 加大研發活動投入
    • 微創手術越來越受歡迎
    • 道路交通事故和運動相關傷害的數量增加
    • 越來越多的人擔心肥胖會導致軟骨損失
  • 抑制因素
    • 膝關節軟骨修復手術和治療費用高
    • 老年人膝關節軟骨修復手術相關併發症
    • 基於軟骨的干細胞產品數量的限制
  • 市場機會
    • 膝關節軟骨修復的技術升級和進步
    • 不健康的生活方式導致骨關節炎患病率增加
    • 由於體育活動的興起,年輕人膝關節受傷率上升
    • 優惠的兌換政策
  • 挑戰
    • 缺乏熟練的醫療專業人員
    • 嚴格的政府法規

第 11 章北美膝關節軟骨修復市場:COVID-19 的影響

  • 對需求的影響
  • 對供應的影響
  • 對價格的影響
  • 政府和製造商的戰略決策
  • 結論

第 12 章北美膝關節軟骨修復市場:按治療

  • 概述
  • 細胞基礎
    • 軟骨細胞移植
    • 幹細胞
    • 增長因素
  • 非基於細胞
    • 組織基礎
    • 無細胞複合材料

第 13 章北美膝關節軟骨修復市場:通過手術

  • 概述
  • 自體□□軟骨細胞移植
  • 微骨折
  • 磨損性關節置換術
  • 挖掘
  • 骨軟骨自體移植
  • 骨軟骨同種異體移植
  • 其他

第 14 章北美膝關節軟骨修復市場:按設備

  • 概述
  • 種植體
    • 按設計類型
    • 按固定
    • 按材料
  • 關節鏡
    • 去除或修復撕裂的半月板
    • 重建撕裂的前交叉韌帶
    • 去除發炎的滑膜組織
    • 修剪受損的軟骨
    • 去除鬆散的骨頭或軟骨碎片
    • 髕骨(膝蓋骨)問題的治療
    • 治療膝關節化膿(感染)
  • 表面重修
  • 截骨術
    • 股骨(THIGHBONE)
    • 脛骨 (SHINBONE)
  • 骨移植
    • 同種異體移植
    • 綜合
  • 關節固定術
  • 其他

第 15 章北美膝關節軟骨修復市場:按應用

  • 概述
  • 骨關節炎
  • 類風濕性關節炎
  • 骨梗塞
  • 骨折
  • 骨腫瘤
  • 其他

第 16 章北美膝關節軟骨修復市場:由最終用戶

  • 概述
  • 醫院
    • 按類型
    • 按尺寸
  • 門診手術中心
  • 獨立中心

第 17 章北美膝關節軟骨修復市場:按分銷渠道

  • 概述
  • 直銷
  • 第三方分發
  • 網上銷售
  • 其他

第 18 章北美膝關節軟骨修復市場:按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥

第 19 章北美膝關節軟骨修復市場:企業現狀

  • 公司份額分析:北美

第 20 章SWOT分析

第 21 章公司簡介

  • ZIMMER BIOMET
    • 公司快照
    • 收入分析
    • 公司股票分析
    • 產品組合
    • 近期發展
    • SWOT 分析
  • STRYKER
    • 公司快照
    • 收入分析
    • 公司股票分析
    • 產品組合
    • 近期發展
    • SWOT 分析
  • B. BRAUN MELSUNGEN AG
    • 公司快照
    • 收入分析
    • 公司股票分析
    • 產品組合
    • 近期發展
    • SWOT 分析
  • VERICEL CORPORATION
    • 公司快照
    • 收入分析
    • 公司股票分析
    • 產品組合
    • 近期發展
    • SWOT 分析
  • SMITH+NEPHEW
    • 公司快照
    • 收入分析
    • 公司股票分析
    • 產品組合
    • 近期發展
    • SWOT 分析
  • ARTHREX, INC.
    • 公司快照
    • 產品組合
    • 近期發展
  • AUXEIN MEDICAL
    • 公司快照
    • 產品組合
    • 近期發展
  • BIOTISSUE SA
    • 公司快照
    • 產品組合
    • 近期發展
  • CARTIHEAL, INC.
    • 公司快照
    • 產品組合
    • 近期發展
  • CONMED CORPORATION
    • 公司快照
    • 收入分析
    • 產品組合
    • 近期發展
  • DEPUY SYNTHES(JOHNSON & JOHNSON 骨科手術公司)
    • 公司快照
    • 收入分析
    • 產品組合
    • 近期發展
  • EVOLUTIS INDIA PVT. LTD.
    • 公司快照
    • 產品組合
    • 近期發展
  • ISTO TECHNOLOGIES, INC.
    • 公司快照
    • 產品組合
    • 近期發展
  • JAPAN MDM, INC.
    • 公司快照
    • 產品組合
    • 近期發展
  • JRI ORTHOPAEDICS
    • 公司快照
    • 產品組合
    • 近期發展
  • MATHYS AG BETTLACH
    • 公司快照
    • 產品組合
    • 近期發展
  • MEDACTA INTERNATIONAL
    • 公司快照
    • 收入分析
    • 產品組合
    • 近期發展
  • MERIL LIFE SCIENCES PVT. LTD.
    • 公司快照
    • 產品組合
    • 近期發展
  • REGENTIS BIOMATERIALS LTD.
    • 公司快照
    • 產品組合
    • 近期發展
  • TEIJIN NAKASHIMA MEDICAL CO., LTD.
    • 公司快照
    • 產品組合
    • 近期發展
  • THE FUTURE OF BIOTECHNOLOGY, MEDIPOST
    • 公司快照
    • 收入分析
    • 產品組合
    • 近期發展
  • WALDEMAR LINK GMBH & CO. KG
    • 公司快照
    • 產品組合
    • 近期發展

第 22 章問卷

第 23 章相關報導

目錄

North America knee cartilage repair market is projected to register a CAGR of 8.0% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

North America Knee Cartilage Repair Market By Treatment (Cell-Based and Non-cell-based), Surgery, (Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Micro Fracture, Drilling, Abrasion Arthroplasty, Autologous Chondrocyte Implantation, and Others), Devices (Implants, Osteotomy, Bone Grafts, Arthroscopy, Resurfacing, Arthrodesis, and Others), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fractures, Bone Tumours, and Others), End User (Hospital, Ambulatory Surgical Centres, and Independent Centres) Distribution Channel (Third Party Distributor, Online Sales, Direct Sales, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast To 2028.

Some of the major factors contributing to the growth of the North America knee cartilage repair market are:

  • Increase in investments in research and development activities
  • increase in number of road accidents and sports-related Injuries

Market Players:

The key market players for North America knee cartilage repair market are listed below:

  • Smith+Nephew
  • Stryker
  • JRI Orthopaedics
  • Auxein Medical
  • Regentis Biomaterials Ltd.
  • EVOLUTIS INDIA PVT. LTD.
  • Japan MDM, Inc.
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • The Future of Biotechnology, MEDIPOST
  • Vericel Corporation
  • CONMED Corporation
  • TEIJIN NAKASHIMA MEDICAL CO., LTD.
  • BioTissue
  • ISTO Technologies, Inc.
  • CartiHeal, Inc.
  • Mathys AG Bettlach
  • DePuy Synthes (The Orthopedic franchise of Johnson & Johnson Services, Inc.)
  • Meril Life Sciences Pvt. Ltd.
  • Arthrex, Inc.
  • Medacta International
  • Waldemar Link GmbH & Co. KG

TABLE OF CONTENTS

1 INTRODUCTION 42

  • 1.1 OBJECTIVES OF THE STUDY 42
  • 1.2 MARKET DEFINITION 42
  • 1.3 OVERVIEW OF NORTH AMERICA KNEE CARTILAGE REPAIR MARKET 42
  • 1.4 LIMITATIONS 44
  • 1.5 MARKETS COVERED 44

2 MARKET SEGMENTATION 47

  • 2.1 MARKETS COVERED 47
  • 2.2 GEOGRAPHICAL SCOPE 48
  • 2.3 YEARS CONSIDERED FOR THE STUDY 49
  • 2.4 CURRENCY AND PRICING 49
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
  • 2.6 MULTIVARIATE MODELLING 53
  • 2.7 TREATMENT LIFELINE CURVE 53
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
  • 2.9 DBMR MARKET POSITION GRID 55
  • 2.10 VENDOR SHARE ANALYSIS 57
  • 2.11 SECONDARY SOURCES 58
  • 2.12 ASSUMPTIONS 58

3 EXECUTIVE SUMMARY 59

4 PREMIUM INSIGHTS 62

5 REGULATIONS FOR KNEE CARTILAGE REPAIR MARKET 63

  • 5.1 USFDA 63
  • 5.2 CLINICAL APPROVALS FOR DIFFERENT PRODUCTS: 63
    • 5.2.1 AUTOLOGOUS CELLULAR PRODUCTS 63
    • 5.2.2 ALLOGENEIC CELLULAR PRODUCTS 63
    • 5.2.3 INJECTABLE DRUGS 64
    • 5.2.4 DEVICES 64
    • 5.2.5 NONCLINICAL DATA AND TESTING 64
  • 5.3 CLINICAL TRIALS, PATIENT POPULATION, AND CLINICAL ENDPOINTS 65
    • 5.3.1 PATIENT POPULATION 65
    • 5.3.2 CHOICE OF COMPARATOR GROUP 65
    • 5.3.3 CLINICAL ENDPOINTS 65

6 EPIDEMIOLOGY 68

7 INDUSTRIAL INSIGHTS 69

8 REIMBURSEMENT FOR KNEE CARTILAGE REPAIR 70

9 VALUE CHAIN OF NORTH AMERICA KNEE CARTILAGE REPAIR MARKET 73

10 MARKET OVERVIEW 74

  • 10.1 DRIVERS 76
    • 10.1.1 INCREASE IN NUMBER OF OLD AGE POPULATION 76
    • 10.1.2 INCREASE IN INVESTMENTS IN RESEARCH AND DEVELOPMENT ACTIVITIES 77
    • 10.1.3 RISE IN POPULARITY OF MINIMAL INVASIVE PROCEDURES 78
    • 10.1.4 INCREASE IN THE NUMBER OF ROAD ACCIDENTS AND SPORTS-RELATED INJURIES 78
    • 10.1.5 RISE IN OBESITY CONCERNS AMONG THE POPULATION EVENTUALLY LEADS TO CARTILAGE LOSS 79
  • 10.2 RESTRAINTS 80
    • 10.2.1 HIGH COST OF KNEE CARTILAGE REPAIR SURGERIES & TREATMENT 80
    • 10.2.2 COMPLICATIONS ASSOCIATED WITH KNEE CARTILAGE REPAIR SURGERIES IN ELDER POPULATION 80
    • 10.2.3 LIMITED NUMBER OF CARTILAGE-BASED STEM CELL PRODUCTS 81
  • 10.3 OPPORTUNITIES 82
    • 10.3.1 TECHNOLOGICAL UPGRADATION AND ADVANCEMENT IN KNEE CARTILAGE REPAIR 82
    • 10.3.2 INCREASE IN THE PREVALENCE OF OA (OSTEOARTHRITIS) DUE TO AN UNHEALTHY LIFESTYLE 82
    • 10.3.3 RISE IN KNEE INJURIES AMONG YOUNGSTERS DUE TO RISE IN SPORTS ACTIVITIES 83
    • 10.3.4 FAVORABLE REIMBURSEMENT POLICIES 84
  • 10.4 CHALLENGES 85
    • 10.4.1 LACK OF SKILLED MEDICAL PROFESSIONALS 85
    • 10.4.2 STRINGENT GOVERNMENT REGULATIONS 85

11 COVID-19 IMPACT ON NORTH AMERICA KNEE CARTILAGE REPAIR MARKET 87

  • 11.1 IMPACT ON DEMAND 87
  • 11.2 IMPACT ON SUPPLY 88
  • 11.3 IMPACT ON PRICE 88
  • 11.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS 89
  • 11.5 CONCLUSION 89

12 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY TREATMENT 90

  • 12.1 OVERVIEW 91
  • 12.2 CELL BASED 92
    • 12.2.1 CHONDROCYTE TRANSPLANTATION 93
    • 12.2.2 STEM CELLS 93
    • 12.2.3 GROWTH FACTORS 93
  • 12.3 NON CELL BASED 93
    • 12.3.1 TISSUE SCAFFOLDS 94
    • 12.3.2 CELL-FREE COMPOSITES 94

13 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY SURGERY 95

  • 13.1 OVERVIEW 96
  • 13.2 AUTOLOGOUS CHONDROCYTE IMPLANTATION 97
  • 13.3 MICROFRACTURE 98
  • 13.4 ABRASION ARTHROPLASTY 98
  • 13.5 DRILLING 99
  • 13.6 OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION 100
  • 13.7 OSTEOCHONDRAL ALLOGRAFT TRANSPLANTATION 101
  • 13.8 OTHERS 102

14 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DEVICES 103

  • 14.1 OVERVIEW 104
  • 14.2 IMPLANTS 105
    • 14.2.1 BY DESIGN TYPE 106
      • 14.2.1.1 POSTERIOR-STABILIZED DESIGNS 106
      • 14.2.1.2 CRUCIATE-RETAINING DESIGNS 106
      • 14.2.1.3 BICRUCIATE-RETAINING DESIGNS 106
    • 14.2.2 BY FIXATION 106
      • 14.2.2.1 CEMENTED 107
      • 14.2.2.2 CEMENT LESS 107
      • 14.2.2.3 HYBRID 107
    • 14.2.3 BY MATERIALS 107
      • 14.2.3.1 POLYETHYLENE 107
      • 14.2.3.2 TITANIUM 107
      • 14.2.3.3 COBALT-CHROMIUM BASED ALLOYS 107
      • 14.2.3.4 CERAMICS 107
      • 14.2.3.5 OTHERS 107

  • 14.3 ARTHROSCOPY 108
    • 14.3.1 REMOVAL OR REPAIR OF A TORN MENISCUS 109
    • 14.3.2 RECONSTRUCTION OF A TORN ANTERIOR CRUCIATE LIGAMENT 109
    • 14.3.3 REMOVAL OF INFLAMED SYNOVIAL TISSUE 109
    • 14.3.4 TRIMMING OF DAMAGED ARTICULAR CARTILAGE 109
    • 14.3.5 REMOVAL OF LOOSE FRAGMENTS OF BONE OR CARTILAGE 109
    • 14.3.6 TREATMENT OF PATELLA (KNEECAP) PROBLEMS 109
    • 14.3.7 TREATMENT OF KNEE SEPSIS (INFECTION) 109
  • 14.4 RESURFACING 110
  • 14.5 OSTEOTOMY 111
    • 14.5.1 FEMUR (THIGHBONE) 112
    • 14.5.2 TIBIA (SHINBONE) 112
  • 14.6 BONE GRAFT 112
    • 14.6.1 ALLOGRAFTS 113
    • 14.6.2 SYNTHETIC 113
  • 14.7 ARTHRODESIS 113
  • 14.8 OTHERS 114

15 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION 115

  • 15.1 OVERVIEW 116
  • 15.2 OSTEOARTHRITIS 117
  • 15.3 RHEMATOID ARTHRITIS 118
  • 15.4 OSTEONECROSIS 118
  • 15.5 FRACTURE 119
  • 15.6 BONE TUMOR 120
  • 15.7 OTHERS 121

16 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY END USER 122

  • 16.1 OVERVIEW 123
  • 16.2 HOSPITAL 124
    • 16.2.1 BY TYPE 125
      • 16.2.1.1 PRIVATE 125
      • 16.2.1.2 PUBLIC 125
    • 16.2.2 BY SIZE 125
      • 16.2.2.1 LARGE 125
      • 16.2.2.2 MEDIUM 126
      • 16.2.2.3 SMALL 126
  • 16.3 AMBULATORY SURGICAL CENTERS 126
  • 16.4 INDEPENDENT CENTERS 127

17 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL 128

  • 17.1 OVERVIEW 129
  • 17.2 DIRECT SALE 130
  • 17.3 THIRD PARTY DISTRIBUTOR 131
  • 17.4 ONLINE SALES 131
  • 17.5 OTHERS 132

18 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY REGION 133

  • 18.1 NORTH AMERICA 134
    • 18.1.1 U.S. 143
    • 18.1.2 CANADA 148
    • 18.1.3 MEXICO 153

19 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: COMPANY LANDSCAPE 158

  • 19.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 158

20 SWOT ANALYSIS 159

21 COMPANY PORFILE 160

  • 21.1 ZIMMER BIOMET 160
    • 21.1.1 COMPANY SNAPSHOT 160
    • 21.1.2 REVENUE ANALYSIS 160
    • 21.1.3 COMPANY SHARE ANALYSIS 161
    • 21.1.4 PRODUCT PORTFOLIO 161
    • 21.1.5 RECENT DEVELOPMENTS 161
    • 21.1.6 SWOT ANALYSIS 162
  • 21.2 STRYKER 163
    • 21.2.1 COMPANY SNAPSHOT 163
    • 21.2.2 REVENUE ANALYSIS 163
    • 21.2.3 COMPANY SHARE ANALYSIS 164
    • 21.2.4 PRODUCT PORTFOLIO 164
    • 21.2.5 RECENT DEVELOPMENTS 164
    • 21.2.6 SWOT ANALYSIS 165
  • 21.3 B. BRAUN MELSUNGEN AG 166
    • 21.3.1 COMPANY SNAPSHO 166
    • 21.3.2 REVENUE ANALYSIS 166
    • 21.3.3 COMPANY SHARE ANALYSIS 167
    • 21.3.4 PRODUCT PORTFOLIO 167
    • 21.3.5 RECENT DEVELOPMENT 167
    • 21.3.6 SWOT ANALYSIS 168
  • 21.4 VERICEL CORPORATION 169
    • 21.4.1 COMPANY SNAPSHOT 169
    • 21.4.2 REVENUE ANALYSIS 169
    • 21.4.3 COMPANY SHARE ANALYSIS 170
    • 21.4.4 PRODUCT PORTFOLIO 170
    • 21.4.5 RECENT DEVELOPMENT 170
    • 21.4.6 SWOT ANALYSIS 171
  • 21.5 SMITH+NEPHEW 172
    • 21.5.1 COMPANY SNAPSHOT 172
    • 21.5.2 REVENUE ANALYSIS 172
    • 21.5.3 COMPANY SHARE ANALYSIS 173
    • 21.5.4 PRODUCT PORTFOLIO 173
    • 21.5.5 RECENT DEVELOPMENTS 173
    • 21.5.6 SWOT ANALYSIS 174
  • 21.6 ARTHREX, INC. 175
    • 21.6.1 COMPANY SNAPSHOT 175
    • 21.6.2 PRODUCT PORTFOLIO 175
    • 21.6.3 RECENT DEVELOPMENT 175
  • 21.7 AUXEIN MEDICAL 176
    • 21.7.1 COMPANY SNAPSHOT 176
    • 21.7.2 PRODUCT PORTFOLIO 176
    • 21.7.3 RECENT DEVELOPMENT 176
  • 21.8 BIOTISSUE SA 177
    • 21.8.1 COMPANY SNAPSHOT 177
    • 21.8.2 PRODUCT PORTFOLIO 177
    • 21.8.3 RECENT DEVELOPMENT 177
  • 21.9 CARTIHEAL, INC. 178
    • 21.9.1 COMPANY SNAPSHOT 178
    • 21.9.2 PRODUCT PORTFOLIO 178
    • 21.9.3 RECENT DEVELOPMENTS 178
  • 21.10 CONMED CORPORATION 179
    • 21.10.1 COMPANY SNAPSHOT 179
    • 21.10.2 REVENUE ANALYSIS 179
    • 21.10.3 PRODUCT PORTFOLIO 180
    • 21.10.4 RECENT DEVELOPMENT 180
  • 21.11 DEPUY SYNTHES (THE ORTHOPEDIC COMPANY OF JOHNSON & JOHNSON) 181
    • 21.11.1 COMPANY SNAPSHOT 181
    • 21.11.2 REVENUE ANALYSIS 181
    • 21.11.3 PRODUCT PORTFOLIO 182
    • 21.11.4 RECENT DEVELOPMENT 182
  • 21.12 EVOLUTIS INDIA PVT. LTD. 183
    • 21.12.1 COMPANY SNAPSHOT 183
    • 21.12.2 PRODUCT PORTFOLIO 183
    • 21.12.3 RECENT DEVELOPMENT 183
  • 21.13 ISTO TECHNOLOGIES, INC. 184
    • 21.13.1 COMPANY SNAPSHOT 184
    • 21.13.2 PRODUCT PORTFOLIO 184
    • 21.13.3 RECENT DEVELOPMENTS 184
  • 21.14 JAPAN MDM, INC. 186
    • 21.14.1 COMPANY SNAPSHOT 186
    • 21.14.2 PRODUCT PORTFOLIO 186
    • 21.14.3 RECENT DEVELOPMENT 186
  • 21.15 JRI ORTHOPAEDICS 187
    • 21.15.1 COMPANY SNAPSHOT 187
    • 21.15.2 PRODUCT PORTFOLIO 187
    • 21.15.3 RECENT DEVELOPMENT 187
  • 21.16 MATHYS AG BETTLACH 188
    • 21.16.1 COMPANY SNAPSHOT 188
    • 21.16.2 PRODUCT PORTFOLIO 188
    • 21.16.3 RECENT DEVELOPMENT 188
  • 21.17 MEDACTA INTERNATIONAL 189
    • 21.17.1 COMPANY SNAPSHOT 189
    • 21.17.2 REVENUE ANALYSIS 189
    • 21.17.3 PRODUCT PORTFOLIO 190
    • 21.17.4 RECENT DEVELOPMENTS 190
  • 21.18 MERIL LIFE SCIENCES PVT. LTD. 191
    • 21.18.1 COMPANY SNAPSHOT 191
    • 21.18.2 PRODUCT PORTFOLIO 191
    • 21.18.3 RECENT DEVELOPMENTS 191
  • 21.19 REGENTIS BIOMATERIALS LTD. 193
    • 21.19.1 COMPANY SNAPSHOT 193
    • 21.19.2 PRODUCT PORTFOLIO 193
    • 21.19.3 RECENT DEVELOPMENT 193
  • 21.20 TEIJIN NAKASHIMA MEDICAL CO., LTD. 194
    • 21.20.1 COMPANY SNAPSHOT 194
    • 21.20.2 PRODUCT PORTFOLIO 194
    • 21.20.3 RECENT DEVELOPMENT 194

  • 21.21 THE FUTURE OF BIOTECHNOLOGY, MEDIPOST 195
    • 21.21.1 COMPANY SNAPSHOT 195
    • 21.21.2 REVENUE ANALYSIS 195
    • 21.21.3 PRODUCT PORTFOLIO 196
    • 21.21.4 RECENT DEVELOPMENTS 196
  • 21.22 WALDEMAR LINK GMBH & CO. KG 197
    • 21.22.1 COMPANY SNAPSHOT 197
    • 21.22.2 PRODUCT PORTFOLIO 197
    • 21.22.3 RECENT DEVELOPMENT 197

22 QUESTIONNAIRE 198

23 RELATED REPORTS 202

LIST OF TABLES

  • TABLE 1 FOOD AND DRUG ADMINISTRATION APPROVAL PATHWAYS FOR CARTILAGE REPAIR PRODUCTS 39
  • TABLE 2 NUMBER OF INDIVIDUALS AGED 65 YEARS OR OVER BY GEOGRAPHICAL REGION, 2019 AND 2050 52
  • TABLE 3 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2019-2028 (USD MILLION) 68
  • TABLE 4 NORTH AMERICA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 68
  • TABLE 5 NORTH AMERICA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, 2015-2018 (USD MILLION) 69
  • TABLE 6 NORTH AMERICA NON CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 70
  • TABLE 7 NORTH AMERICA NON CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2018 (USD MILLION) 70
  • TABLE 8 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2015-2018 (USD MILLION) 73
  • TABLE 9 NORTH AMERICA AUTOLOGOUS CHONDROCYTE IMPLANTATION IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 73
  • TABLE 10 NORTH AMERICA MICROFRACTURE IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 74
  • TABLE 11 NORTH AMERICA ABRASION ARTHROPLASTY IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 75
  • TABLE 12 NORTH AMERICA DRILLING IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 75
  • TABLE 13 NORTH AMERICA OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 76
  • TABLE 14 NORTH AMERICA OSTEOCHONDRAL ALLOGRAFT TRANSPLANTATION IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 77
  • TABLE 15 NORTH AMERICA OTHERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 78
  • TABLE 16 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2018 (USD MILLION) 81
  • TABLE 17 NORTH AMERICA IMPLANTS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 81
  • TABLE 18 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DESIGN TYPE, 2015-2018 (USD MILLION) 82
  • TABLE 19 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY FIXATION, 2015-2018 (USD MILLION) 82
  • TABLE 20 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY MATERIAL, 2015-2018 (USD MILLION) 83
  • TABLE 21 NORTH AMERICA ARTHROSCOPY IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 84
  • TABLE 22 NORTH AMERICA ARTHRODESIS IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2018 (USD MILLION) 85
  • TABLE 23 NORTH AMERICA RESURFACING IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 86
  • TABLE 24 NORTH AMERICA OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 87
  • TABLE 25 NORTH AMERICA OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2018 (USD MILLION) 87
  • TABLE 26 NORTH AMERICA BONE GRAFT IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 88
  • TABLE 27 NORTH AMERICA BONE GRAFT IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2018 (USD MILLION) 89
  • TABLE 28 NORTH AMERICA ARTHRODESIS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 90
  • TABLE 29 NORTH AMERICA OTHERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 90
  • TABLE 30 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2015-2018 (USD MILLION) 93
  • TABLE 31 NORTH AMERICA OSTEOARTHRITIS KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 93
  • TABLE 32 NORTH AMERICA RHEMATOID ARTHRITIS IN KNEE CARTILAGE REPAIR MARKET, BY REGION 2015-2018 (USD MILLION) 94
  • TABLE 33 NORTH AMERICA OSTEONECROSIS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 95
  • TABLE 34 NORTH AMERICA FRACTURE KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 95
  • TABLE 35 NORTH AMERICA BONE TUMOR KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 96
  • TABLE 36 NORTH AMERICA OTHERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 97
  • TABLE 37 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2018 (USD MILLION) 100
  • TABLE 38 NORTH AMERICA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 100
  • TABLE 39 NORTH AMERICA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2018 (USD MILLION) 101
  • TABLE 40 NORTH AMERICA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2018 (USD MILLION) 101
  • TABLE 41 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 102
  • TABLE 42 NORTH AMERICA INDEPENDENT CENTERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 103
  • TABLE 43 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2015-2018 (USD MILLION) 106
  • TABLE 44 NORTH AMERICA DIRECT SALES IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 106
  • TABLE 45 NORTH AMERICA THIRD PARTY DISTRIBUTOR IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 107
  • TABLE 46 NORTH AMERICA ONLINE SALES IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 107
  • TABLE 47 NORTH AMERICA OTHERS IN KNEE CARTILAGE REPAIR MARKET, BY REGION, 2015-2018 (USD MILLION) 108
  • TABLE 48 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY COUNTRY, 2015-2028 (USD MILLION) 114
  • TABLE 49 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 114
  • TABLE 50 NORTH AMERICA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 114
  • TABLE 51 NORTH AMERICA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 114
  • TABLE 52 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2015-2028 (USD MILLION) 115
  • TABLE 53 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 115
  • TABLE 54 NORTH AMERICA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY DESIGN TYPE, 2015-2028 (USD MILLION) 115
  • TABLE 55 NORTH AMERICA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY FIXATION, 2015-2028 (USD MILLION) 116
  • TABLE 56 NORTH AMERICA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY MATERIAL, 2015-2028 (USD MILLION) 116
  • TABLE 57 NORTH AMERICA OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 116
  • TABLE 58 NORTH AMERICA BONE GRAFTS IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 116
  • TABLE 59 NORTH AMERICA ARTHROSCOPY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 117
  • TABLE 60 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2015-2028 (USD MILLION) 117
  • TABLE 61 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2028 (USD MILLION) 118
  • TABLE 62 NORTH AMERICA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2015-2028 (USD MILLION) 118
  • TABLE 63 NORTH AMERICA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2015-2028 (USD MILLION) 118
  • TABLE 64 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION) 118
  • TABLE 65 U.S. KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 119
  • TABLE 66 U.S. NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT,2015-2028 (USD MILLION) 119
  • TABLE 67 U.S. CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 119
  • TABLE 68 U.S. KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2015-2028 (USD MILLION) 120
  • TABLE 69 U.S. KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 120
  • TABLE 70 U.S. IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY DESIGN TYPE, 2015-2028 (USD MILLION) 120
  • TABLE 71 U.S. IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY FIXATION, 2015-2028 (USD MILLION) 121
  • TABLE 72 U.S. IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY MATERIAL, 2015-2028 (USD MILLION) 121
  • TABLE 73 U.S. OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 121
  • TABLE 74 U.S. BONE GRAFTS IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 121
  • TABLE 75 U.S. ARTHROSCOPY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 122
  • TABLE 76 U.S. KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2015-2028 (USD MILLION) 122
  • TABLE 77 U.S. KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2028 (USD MILLION) 122
  • TABLE 78 U.S. HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2015-2028 (USD MILLION) 123
  • TABLE 79 U.S. HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2015-2028 (USD MILLION) 123
  • TABLE 80 U.S. KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION) 123
  • TABLE 81 CANADA KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 124
  • TABLE 82 CANADA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT 2015-2028 (USD MILLION) 124
  • TABLE 83 CANADA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 124
  • TABLE 84 CANADA KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2015-2028 (USD MILLION) 125
  • TABLE 85 CANADA KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 125
  • TABLE 86 CANADA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY DESIGN TYPE, 2015-2028 (USD MILLION) 125
  • TABLE 87 CANADA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY FIXATION, 2015-2028 (USD MILLION) 126
  • TABLE 88 CANADA IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY MATERIAL, 2015-2028 (USD MILLION) 126
  • TABLE 89 CANADA OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 126
  • TABLE 90 CANADA BONE GRAFTS IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 126
  • TABLE 91 CANADA ARTHROSCOPY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 127
  • TABLE 92 CANADA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2015-2028 (USD MILLION) 127
  • TABLE 93 CANADA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2028 (USD MILLION) 127
  • TABLE 94 CANADA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2015-2028 (USD MILLION) 128
  • TABLE 95 CANADA HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2015-2028 (USD MILLION) 128
  • TABLE 96 CANADA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION) 128
  • TABLE 97 MEXICO KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 129
  • TABLE 98 MEXICO NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT 2015-2028 (USD MILLION) 129
  • TABLE 99 MEXICO CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2015-2028 (USD MILLION) 129
  • TABLE 100 MEXICO KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2015-2028 (USD MILLION) 130
  • TABLE 101 MEXICO KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 130
  • TABLE 102 MEXICO IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY DESIGN TYPE, 2015-2028 (USD MILLION) 130
  • TABLE 103 MEXICO IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY FIXATION, 2015-2028 (USD MILLION) 131
  • TABLE 104 MEXICO IMPLANT IN KNEE CARTILAGE REPAIR MARKET, BY MATERIAL, 2015-2028 (USD MILLION) 131
  • TABLE 105 MEXICO OSTEOTOMY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 131
  • TABLE 106 MEXICO BONE GRAFTS IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 131
  • TABLE 107 MEXICO ARTHROSCOPY IN KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2015-2028 (USD MILLION) 132
  • TABLE 108 MEXICO KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2015-2028 (USD MILLION) 132
  • TABLE 109 MEXICO KNEE CARTILAGE REPAIR MARKET, BY END USER, 2015-2028 (USD MILLION) 132
  • TABLE 110 MEXICO HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2015-2028 (USD MILLION) 133
  • TABLE 111 MEXICO HOSPITAL IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2015-2028 (USD MILLION) 133
  • TABLE 112 MEXICO KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION) 133

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: SEGMENTATION 22
  • FIGURE 2 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: DATA TRIANGULATION 25
  • FIGURE 3 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET : DROC ANALYSIS 26
  • FIGURE 4 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 27
  • FIGURE 5 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: COMPANY RESEARCH ANALYSIS 27
  • FIGURE 6 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: INTERVIEW DEMOGRAPHICS 29
  • FIGURE 7 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: DBMR MARKET POSITION GRID 30
  • FIGURE 8 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: VENDOR SHARE ANALYSIS 32
  • FIGURE 9 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: SEGMENTATION 35
  • FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA KNEE CARTILAGE REPAIR MARKET AND GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 36
  • FIGURE 11 AN INCREASE IN AGING POPULATION AND RISE IN POPULARITY OF MINIMAL INVASIVE PROCEDURES ARE DRIVING THE GROWTH OF NORTH AMERICA KNEE CARTILAGE REPAIR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 37
  • FIGURE 12 CELL-BASED SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA KNEE CARTILAGE REPAIR MARKET IN 2021 & 2028 37
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA KNEE CARTILAGE REPAIR MARKET 50
  • FIGURE 14 POPULATION OF MALES AND FEMALES ABOVE 65 YEARS OF AGE IN 2020 51
  • FIGURE 15 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY TREATMENT, 2020 66
  • FIGURE 16 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY SURGERY, 2020 71
  • FIGURE 17 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DEVICES, 2020 79
  • FIGURE 18 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2020 91
  • FIGURE 19 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY END-USER, 2020 98
  • FIGURE 20 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2020 104
  • FIGURE 21 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: SNAPSHOT (2020) 110
  • FIGURE 22 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2020) 111
  • FIGURE 23 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2021 & 2028) 111
  • FIGURE 24 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2020 & 2028) 112
  • FIGURE 25 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: BY TREATMENT (2021 & 2028) 112
  • FIGURE 26 NORTH AMERICA KNEE CARTILAGE REPAIR MARKET: COMPANY SHARE 2020 (%) 133